Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials. - Jhanji V; Duncan J; Gardner T; Hughes GK; McIntire R; Peña AM; Ladd C; Gardner B; Moore T; Garrett E; Cook C; Haslam A; et al. (Molecular cancer therapeutics, 2025)